Collectively, this integrated protein expression profile defines the CMLPS-N1 cell line as a novel and aggressive breast cancer cell model with a dysfunctional p53 pathway, a pro-metastatic motility signature, and high cyclin-driven proliferative potential. This evidence concerns the gene TP53 and breast carcinoma.